Delivery Order SPE2DB22D3501-SPE2DB25FXK22
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,475.49 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) under a firm fixed price contract. The award was issued on June 26, 2025, with an ultimate completion date of June 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a routine pharmaceutical procurement action within the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,079.18 to supply Nateglinide 120 mg tablets (100-count units) under a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside award was competitively procured and represents a child contract action originating from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nateglinide 60 mg tablets (100-count units) with a ceiling value of $1,554.62. This firm fixed-price delivery order, which has a completion date of September 10, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading pharmaceutical distributors and serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets in quantities of 100 on August 5, 2025, with completion targeted for August 6, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $1,573.16 and operates under firm fixed price terms. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the awardee location....
- The Defense Logistics Agency awarded a delivery order valued at $2,919.52 to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets (100-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Nateglinide is a rapid-acting insulin secretagogue used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Nateglinide 60 mg tablets in quantities of 100 units, with a contract ceiling value of $6,925.84 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nateglinide is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,634.67 firm-fixed-price contract is for the delivery of Nateglinide 60 mg tablets, a type of oral antidiabetic medication. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,181.48 firm-fixed-price delivery order is for the supply of 4,568,061,670 units of the prescription medication Nateglinide 120 mg tablets. The contract has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,133.05 firm-fixed-price delivery order is for the supply of Nateglinide 60 mg Tablet unit doses, with a completion date of September 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery vehicles (IDVs) to provide a wide range of medical commodities,...
- This federal contract award, valued at $1,842.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,875,756 units of the medication Nateglinide 60 mg Tablet in 100-count packages. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 11, 2025. It is not designated as a set-aside contract,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK22Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,694.90 to AmerisourceBergen Drug Corp for 100 tablets of Nateglinide 60 mg, an oral antidiabetic medication. This competitive, non-set-aside delivery order, effective through September 18, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location under firm fixed price terms. The award represents a child contract action under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive federal contract portfolio focused on delivering critical medications and medical commodities to Defense Health Agency customers and other government healthcare systems. The company's DLA Troop Support Medical prime contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, positioning AmerisourceBergen as a key vendor within the federal military healthcare supply chain. This nateglinide delivery order exemplifies the company's role in supplying essential pharmaceutical products to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/17/25 |